国产欧美一区二区精品性色,亚洲精品成人一区,图色欧美一区二区三区,亚洲一区二区三区免费中文字幕

咨詢熱線

15000266580

當前位置：首頁 >產(chǎn)品中心>細胞庫>人正常細胞>TIB-196U266B1細胞， 人外周淋巴細胞

U266B1細胞， 人外周淋巴細胞

簡要描述：U266B1細胞， 人外周淋巴細胞
ATCC 細胞|細胞系|細胞株|腫瘤細胞|細胞|貼壁細胞|懸浮細胞|;細胞庫管理規(guī)范，
提供的細胞株背景清楚，提供參考文獻和培養(yǎng)條件！

  • 產(chǎn)品型號：TIB-196
  • 廠商性質(zhì)：生產(chǎn)廠家
  • 更新時間：2024-08-29
  • 訪  問  量：1712

產(chǎn)品分類

Product Category

相關文章

Related Articles

詳細介紹

U266B1細胞， 人外周淋巴細胞

ATCC® Number:TIB-196™    Price:$269.00
Designations:U266B1 [U266]

Depositors:NK Nilsson

Isotype:IgE; lambda light chain

Biosafety Level:1

Shipped:frozen

Medium & Serum:See Propagation

Growth Properties:suspension

Organism:Homo sapiens (human)

Morphology:lymphoblast


Source:Organ: peripheral blood
Disease: myeloma; plasmacytoma
Cell Type: B lymphocyte;

Cellular Products:immunoglobulin; monoclonal antibody; interleukin 6 (interleukin-6, IL-6)

Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimay responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
U266B1細胞， 人外周淋巴細胞

Applications:transfection host (Nucleofection technology from Lonza)

DNA Profile (STR):Amelogenin: X,Y

CSF1PO: 12,13

D13S317: 12

D16S539: 10

D5S818: 11,12

D7S820: 11,12

THO1: 5,7

TPOX: 8

vWA: 17



Age:53 years adult

Gender:male

Comments:U266 cells have been reported to produce human IL-6.

Propagation:ATCC complete growth medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 15%.

Subculturing:Medium Renewal: Every 2 to 3 days

Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 3 x 10 exp5 cells/ml and maintain between 1 x 10 exp5 and 1 x 10 exp6 cells/ml.



Preservation:culture medium 95%; DMSO, 5%

Related Products:Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001

recommended serum:ATCC 30-2020



References:1180: Nilsson K, et al. Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient. Clin. Exp. Immunol. 7: 477-489, 1970. PubMed: 4097745
22377: Kawano M, et al. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332: 83-85, 1988. PubMed:3258060
32396: Kolanus W, et al. alphaLbeta2 integrin/LFA-1 binding to ICAM-1 induced by cytohesin-1 a cytoplasmic regulatory molecule. Cell 86: 233-242, 1996. PubMed: 8706128
























產(chǎn)品咨詢

留言框

  • 產(chǎn)品：

  • 您的單位：

  • 您的姓名：

  • 聯(lián)系電話：

  • 常用郵箱：

  • 省份：

  • 詳細地址：

  • 補充說明：

  • 驗證碼：

    請輸入計算結果（填寫阿拉伯數(shù)字），如：三加四=7

聯(lián)系方式

郵箱：xiangfbio@163.com

地址：上海市虹口區(qū)四平路710號7層

咨詢熱線

400-821-8510

（周一至周日9:00- 19:00）

在線咨詢

  • 掃一掃 微信咨詢

Copyright©2024 上海復祥生物科技有限公司 All Right Reserved    備案號：滬ICP備10013034號-2     sitemap.xml
技術支持：化工儀器網(wǎng)    管理登陸